India to Brazil: Enoxaparin Export Trade Route
India has recorded 17 verified shipments of Enoxaparin exported to Brazil, representing a combined trade value of $3.0M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $176.0K USD. The leading Indian exporter is GLAND PHARMA LIMITED, which accounts for 50% of total export value with 5 shipments worth $1.5M USD. On the buying side, Mylan Brasil Dist.De Medicamentos is the largest importer in Brazil with $769.6K USD in purchases. The top 3 suppliers — GLAND PHARMA LIMITED, GLAND PHARMA LIMITED , GLAND PHARMA LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Enoxaparin corridor is one of India's established pharmaceutical export routes, with 17 shipments documented worth a combined $3.0M USD. The route is dominated by GLAND PHARMA LIMITED, which alone accounts for roughly 50% of all export value, reflecting the consolidated nature of India's enoxaparin manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $176.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with enoxaparin's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 20.6%, placing it at rank #5 among India's top enoxaparin export destinations globally.
On the import side, key buyers of Indian enoxaparin in Brazil include Mylan Brasil Dist.De Medicamentos , MYLAN BRASIL DIST DE MEDICAMENTOS LTD, MYLAN BRASIL DIST DE MEDICAMENTOS and 3 others. Mylan Brasil Dist.De Medicamentos is the single largest importer with 6 shipments valued at $769.6K USD.
